骨诱导因子(OGN)重组蛋白

Recombinant Osteoglycin (OGN)

OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor

  • 骨诱导因子(OGN)重组蛋白 产品包装(模拟)
  • 骨诱导因子(OGN)重组蛋白 产品包装(模拟)
  • RPC688Ra01.jpg SDS-PAGE图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Rattus norvegicus (Rat,大鼠) 应用(仅供研究使用,不用于临床诊断!)
RPC688Ra01 骨诱导因子(OGN)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAC688Ra01 骨诱导因子(OGN)多克隆抗体 WB; IHC; ICC; IP.
LAC688Ra71 骨诱导因子(OGN)多克隆抗体(生物素标记) WB; IHC; ICC.

参考文献

杂志 参考文献
Bone. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. [pubmed:27836731]
Tohoku journal of experimental medicine Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. [pubmed:28824047]
Molecular Metabolism Osteoglycin, a novel coordinator of bone and glucose homeostasis [Pubmed:29799418]
Journal of Experimental & Clinical Cancer Research Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway [Pubmed:29499765]
Journal of Human Hypertension Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients [Pubmed:29867136]
Cell Reports Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue [Pubmed: 30332637]
J Clin Endocrinol Metab Osteoglycin across the adult lifespan [34850904]
留言咨询